Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EXELIXIS, INC. | EVP and CFO | Common Stock | 1.01M | $39.2M | $38.80 | Mar 31, 2025 | Direct |
EXELIXIS, INC. | EVP and CFO | Common Stock | 2.72K | $106K | $38.80 | Mar 31, 2025 | By 401(k) |
EXELIXIS, INC. | EVP and CFO | Option (right to buy) | 100K | Feb 24, 2025 | Direct | ||
Quince Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 35.3K | Jan 2, 2025 | Direct | ||
Quince Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 27K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | Mar 31, 2025 | 1 | $0 | 4 | Mar 31, 2025 | EVP and CFO |
EXEL | EXELIXIS, INC. | Feb 26, 2025 | 1 | $0 | 4 | Feb 28, 2025 | EVP and CFO |
EXEL | EXELIXIS, INC. | Feb 24, 2025 | 3 | -$508K | 4 | Feb 26, 2025 | EVP and CFO |
EXEL | EXELIXIS, INC. | Feb 15, 2025 | 1 | -$756K | 4 | Feb 19, 2025 | EVP and CFO |
EXEL | EXELIXIS, INC. | Jan 16, 2025 | 2 | -$1.34M | 4 | Jan 17, 2025 | EVP and CFO |
QNCX | Quince Therapeutics, Inc. | Jan 2, 2025 | 1 | $0 | 4 | Jan 8, 2025 | Director |
EXEL | EXELIXIS, INC. | Nov 15, 2024 | 1 | -$614K | 4 | Nov 19, 2024 | EVP and CFO |
EXEL | EXELIXIS, INC. | Aug 9, 2024 | 3 | -$348K | 4 | Aug 9, 2024 | EVP and CFO |
QNCX | Quince Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
EXEL | EXELIXIS, INC. | May 15, 2024 | 3 | -$636K | 4 | May 17, 2024 | EVP and CFO |
EXEL | EXELIXIS, INC. | Feb 23, 2024 | 1 | $0 | 4 | Feb 27, 2024 | EVP and CFO |
EXEL | EXELIXIS, INC. | Jan 11, 2024 | 2 | -$500K | 4 | Jan 16, 2024 | EVP and CFO |
EXEL | EXELIXIS, INC. | Sep 6, 2023 | 2 | -$382K | 4 | Sep 8, 2023 | EVP and CFO |
EXEL | EXELIXIS, INC. | Aug 15, 2023 | 1 | -$174K | 4 | Aug 17, 2023 | EVP and CFO |
EXEL | EXELIXIS, INC. | Aug 3, 2023 | 6 | -$703K | 4 | Aug 7, 2023 | EVP and CFO |
QNCX | Quince Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
EXEL | EXELIXIS, INC. | May 15, 2023 | 2 | -$354K | 4 | May 17, 2023 | EVP and CFO |
EXEL | EXELIXIS, INC. | Apr 3, 2023 | 1 | $0 | 4 | Apr 5, 2023 | EVP and CFO |
EXEL | EXELIXIS, INC. | Feb 15, 2023 | 1 | -$95.4K | 4 | Feb 17, 2023 | EVP and CFO |
EXEL | EXELIXIS, INC. | Nov 15, 2022 | 1 | -$135K | 4 | Nov 17, 2022 | EVP and CFO |
EXEL | EXELIXIS, INC. | Aug 11, 2022 | 3 | -$1.54M | 4 | Aug 12, 2022 | EVP and CFO |
EXEL | EXELIXIS, INC. | Aug 3, 2022 | 2 | -$174K | 4 | Aug 5, 2022 | EVP and CFO |
QNCX | Cortexyme, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
EXEL | EXELIXIS, INC. | May 15, 2022 | 1 | -$170K | 4 | May 17, 2022 | EVP and CFO |
EXEL | EXELIXIS, INC. | Mar 4, 2022 | 1 | $0 | 4 | Mar 8, 2022 | EVP and CFO |
EXEL | EXELIXIS, INC. | Feb 15, 2022 | 2 | -$341K | 4 | Feb 17, 2022 | EVP and CFO |
EXEL | EXELIXIS, INC. | Dec 15, 2021 | 2 | -$87.2K | 4 | Dec 17, 2021 | EVP and CFO |
EXEL | EXELIXIS, INC. | Nov 15, 2021 | 3 | -$1.04M | 4 | Nov 17, 2021 | EVP and CFO |
EXEL | EXELIXIS, INC. | Sep 30, 2021 | 2 | -$177K | 4 | Oct 4, 2021 | EVP and CFO |
EXEL | EXELIXIS, INC. | Sep 21, 2021 | 3 | -$790K | 4 | Sep 23, 2021 | EVP and CFO |
QNCX | Cortexyme, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |